Which Precancers Warrant Treating and When

Do actinic keratoses need to be treated?

Most do get treated, though not urgently the way a diagnosed cancer would be. An actinic keratosis is a patch of skin cells changed by cumulative sun exposure, considered precancerous because a subset progress into squamous cell carcinoma if left alone.

The exact share that progresses is debated and varies by study, which is part of why the decision isn't automatic: treating every faint, barely-there spot on someone with widespread sun damage is a different proposition than treating a single thick, tender lesion on someone with a prior skin cancer. What most guidance agrees on is the direction, not a universal deadline — untreated actinic keratosis is a small, cumulative risk rather than an emergency, and that risk is why most are addressed rather than ignored.

What tips the decision toward treating now?

A few factors push a clinician toward treating sooner rather than watching: a lesion that is thick, scaly, tender, or growing, since those features suggest more advanced change; a history of skin cancer, which raises the stakes of any new precancerous change; immunosuppression, whether from a transplant medication or another condition, which both increases the number of actinic keratoses a person develops and speeds their progression; and simply having many lesions clustered in one area, which favors treating the whole field rather than picking off individual spots one at a time. A single faint, stable spot in someone with low overall risk is more often a candidate for watching, especially if it's in a location that's easy to keep an eye on.

How do clinicians choose between treatment options?

Once treatment is warranted, a clinician is really choosing between two broader strategies. One targets a single spot directly, freezing it with liquid nitrogen in one office visit. The other treats an entire area of chronically sun-exposed skin at once, on the reasoning that the lesions someone can see usually sit inside a wider patch of early, not-yet-visible change 1Ref 1American Family Physician (2007).Treatment Options for Actinic Keratoses.Supports the lesion-directed (cryotherapy) versus field-therapy (5-fluorouracil, imiquimod, diclofenac, photodynamic therapy) framing used to describe how treatment choice depends on the number and pattern of lesions.. A solitary, well-defined lesion is the more straightforward case for freezing; several rough patches scattered across one area, or lesions whose edges blur into the surrounding sun damage, tend to push toward treating the whole field instead.

Weighing the actinic keratosis field treatment options compared against each other — topical 5-fluorouracil, imiquimod, tirbanibulin, and photodynamic therapy, an in-office light-activated treatment for precancers — the real differences come down to how long the course runs, how intense the skin reaction gets along the way, and whether it needs repeat clinic visits or can be done at home 1Ref 1American Family Physician (2007).Treatment Options for Actinic Keratoses.Supports the lesion-directed (cryotherapy) versus field-therapy (5-fluorouracil, imiquimod, diclofenac, photodynamic therapy) framing used to describe how treatment choice depends on the number and pattern of lesions.. Tirbanibulin stands out mainly for shrinking that course down to five days, well under the several weeks some older field options call for, though a shorter course isn't automatically the right fit for every pattern of sun damage.

Do the lips and scalp need a different approach?

Location changes the calculation. Actinic cheilitis, actinic keratosis affecting the lower lip, is treated somewhat more assertively than a similar patch elsewhere, because the lip is a site where progression to squamous cell carcinoma carries a higher risk of spreading. Scalp actinic keratosis in someone with thinning hair also tends to get closer attention, both because scalp skin has taken decades of unshielded sun exposure and because a scalp lesion can be easy to miss without a clinician's exam. Both are still built on the same underlying decision framework — extent, thickness, and individual risk — just with a lower threshold to act.

What if a treated spot comes back?

Recurrence is common enough that it doesn't mean treatment failed. Actinic keratosis reflects years of accumulated sun exposure in the skin, not a single event, so new or recurring spots in the same general area are expected over time rather than a sign that the wrong option was chosen. Understanding why precancers return to sun-damaged skin mostly comes down to that same field of damage regenerating new abnormal cells even after visible ones clear, which is why ongoing skin checks matter more than any single successful treatment.

When is it not actually an actinic keratosis?

The harder question isn't always whether to treat a confirmed actinic keratosis — it's confirming that a spot is one in the first place. A spot standing apart from its neighbors — growing faster, turning tender, developing an open sore, or simply looking wrong compared to the rest of the field — deserves a direct look rather than an assumption that it's just another actinic keratosis.

Sometimes that difference turns out to be squamous cell carcinoma, already established rather than merely threatened. Less often, it's something unrelated entirely, such as melanoma, which follows its own diagnostic path through biopsy and staging, and its own treatment path — surgical removal, checking nearby lymph nodes, and in some cases immunotherapy or a targeted drug 2Ref 2National Cancer Institute (PDQ Adult Treatment Editorial Board) (2025).Melanoma Treatment (PDQ®)–Health Professional Version.Supports the differential point that an atypical or changing lesion may be melanoma rather than actinic keratosis, requiring biopsy-based diagnosis and a different treatment pathway (excision, sentinel node evaluation, immunotherapy or targeted therapy). — none of which overlaps with how actinic keratosis itself is managed. No amount of careful description substitutes for a clinician actually examining the lesion in question, which is the entire reason a routine skin check matters even for someone who feels confident every spot on their own skin is old news.